Multi-zonal liver organoids from human pluripotent stem cells
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Apr 2025 · 1 min read
In brief
In brief
Researchers developed self-assembling liver organoids from human iPSCs that replicate the liver's natural portal-central zonation using ascorbate and bilirubin conditioning. These multi-zonal organoids demonstrate zone-specific metabolic functions and improved survival in bile duct ligation models, offering a novel platform for studying liver development and disease.
Written by the GCMD Library team from the article.
Statements in this article
Distinct hepatocyte subpopulations are spatially segregated along the portal-central axis and are critical to understanding metabolic homeostasis and injury in the liver.
Ascorbate and bilirubin have been described as having a role in directing zonal fates in the liver.
Zonal liver architecture has not yet been replicated in vitro.
A self-assembling zone-specific liver organoid can be developed by co-culturing ascorbate- and bilirubin-enriched hepatic progenitors derived from human induced pluripotent stem cells.
Preconditioned hepatocyte-like cells exhibit zone-specific functions associated with the urea cycle, glutathione synthesis and glutamate synthesis.
Single-nucleus RNA-sequencing analysis of zonally patterned organoids identifies a hepatoblast differentiation trajectory that dictates periportal, interzonal and pericentral human hepatocytes.
Zonal identity is orchestrated by ascorbate- or bilirubin-dependent binding of EP300 to TET1 or HIF1α.
Transplantation of self-assembled zonally patterned human organoids improved survival of immunodeficient rats who underwent bile duct ligation by ameliorating hyperammonaemia and hyperbilirubinaemia.